PDE4-IN-28
PDE4-IN-28 (Compound G1) is a PDE4D inhibitor (IC50: 29 nM) . PDE4-IN-28 inhibits the production of TNF-α and NO (IC50: 13.32 and 2.32 μM, respectively) . PDE4-IN-28 exhibits anti-inflammatory, antibacterial and analgesic effects in a rat pressure ulcer (PU) model and promotes HUVEC cell migration, thereby accelerating wound healing[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial; NO Synthase; Phosphodiesterase (PDE) ; TNF Receptor
Related Pathways
Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology; Neurological Disease
Smiles
O=C1N(C2=C(C(N1C)=O)N(CCC(NNC(C3=NN4C(C5=CC(OCC6CC6)=C(C=C5)OC(F)F)=CC=NC4=C3)=O)=O)C=N2)C
Molecular Formula
C28H27F2N9O6
Molecular Weight
623.57
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MHC II (HLA-DP) (beta chain) (Bra-14), CF594 conjugate, 0.1mg/mL
